151. Tricin 7-glucoside protects against experimental cerebral ischemia by reduction of NF-κB and HMGB1 expression.
- Author
-
Jiang WL, Xu Y, Zhang SP, Zhu HB, and Hou J
- Subjects
- Animals, Apoptosis drug effects, Blood-Brain Barrier drug effects, Blood-Brain Barrier physiopathology, Brain drug effects, Brain metabolism, Brain pathology, Brain physiopathology, Brain Ischemia metabolism, Brain Ischemia pathology, Brain Ischemia physiopathology, Cell Hypoxia drug effects, Cell Line, Cell Survival drug effects, Dose-Response Relationship, Drug, Down-Regulation drug effects, Flavonoids administration & dosage, Glucosides administration & dosage, Humans, Male, Neurons drug effects, Neurons metabolism, Neurons pathology, Neuroprotective Agents administration & dosage, Random Allocation, Rats, Rats, Sprague-Dawley, Brain Ischemia drug therapy, Flavonoids therapeutic use, Glucosides therapeutic use, HMGB1 Protein metabolism, NF-kappa B metabolism, Neuroprotective Agents therapeutic use, Reperfusion Injury prevention & control
- Abstract
There have been several studies of nuclear factor-κB (NF-κB) and high-mobility group box1 (HMGB1) associated with the pathophysiology of cerebral ischemia. Tricin 7-glucoside, a major bioactive compound extracted from Sedum sarmentosum Bunge. The objectives of this study were to determine the effects of Tricin 7-glucoside on a cultured neuronal cell line, SH-SY5Y in vitro and experimental ischemic stroke in vivo. For oxygen-glucose deprivation (OGD) and tumor necrosis factor-α (TNF-α) stimulated SH-SY5Y cell line in vitro, SH-SY5Y cells were incubated with Tricin 7-glucoside. For in vivo experiment, rats were subjected to middle cerebral artery occlusion (MACO) for 1h, then followed by reperfusion for 23 h. Treatment of SH-SY5Y cells with Tricin 7-glucoside reduced the OGD-induced apoptosis and cytotoxicity, blocked TNF-α-induced NF-κB and IκB-α phosphorylation, and decreased HMGB1 expression. At doses higher than 50mg/kg, Tricin 7-glucoside produced a significant neuroprotective potential in rats with ischemia and reperfusion (I/R). Tricin 7-glucoside (100mg/kg) demonstrated significant neuroprotective activity even after delayed administration at 2h and 4h after I/R. Tricin 7-glucoside 100mg/kg attenuated histopathological damage, decreased brain edema, inhibited NF-κB activation and reduced HMGB1 expression. These data show that Tricin 7-glucoside protects brain against I/R injury with a favorable therapeutic time-window by alleviating cerebral I/R injury and attenuating blood-brain barrier (BBB) breakdown, and its protective effects may involve HMGB1 and NF-κB signaling pathway., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF